Five Prime Therapeutics, Inc. (FPRX): Price and Financial Metrics
Five Prime Therapeutics, Inc. (FPRX)
Today's Latest Price: $6.12 USD
0.29 (-4.52%)
Updated Jul 2 4:00pm
Add FPRX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
FPRX Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for FPRX is 0.13 -- better than only 13.98% of US stocks.
- FPRX's price/sales ratio is 12.46; that's higher than the P/S ratio of 89.49% of US stocks.
- Revenue growth over the past 12 months for Five Prime Therapeutics Inc comes in at -21.07%, a number that bests only 9.77% of the US stocks we're tracking.
- Stocks that are quantitatively similar to FPRX, based on their financial statements, market capitalization, and price volatility, are APTX, RGNX, ASMB, RARE, and MEIP.
- FPRX's SEC filings can be seen here. And to visit Five Prime Therapeutics Inc's official web site, go to www.fiveprime.com.
FPRX Daily Price Range
FPRX 52-Week Price Range
FPRX Stock Price Chart Technical Analysis Charts
FPRX Price/Volume Stats
| Current price | $6.12 | 52-week high | $7.25 |
| Prev. close | $6.41 | 52-week low | $1.75 |
| Day low | $6.08 | Volume | 243,440 |
| Day high | $6.58 | Avg. volume | 443,943 |
| 50-day MA | $4.67 | Dividend yield | N/A |
| 200-day MA | $4.16 | Market Cap | 224.21M |
Five Prime Therapeutics, Inc. (FPRX) Company Bio
Five Prime Therapeutics discovers and develops innovative therapeutics to improve the lives of patients with serious diseases. The company was founded in 2001 and is based in South San Francisco, California.
Loading social stream, please wait...